Summary

Patients with peripheral artery disease often experience difficulty walking and painful cramps because of the narrowing of arteries in the legs. This painful condition, known as intermittent claudication (IC), can range in severity from being mildly irritating to extremely debilitating. The efficacy and safety of VLTS-934, a compound believed to increase microvascular blood flow, was evaluated in a Phase 2b randomized, double-blind, placebo-controlled multicenter trial of patients with IC conducted in the United States.